Analytical Data
-
基因名
RUNDC3B
- Application
-
别名
RUNDC3B; RPIB9; RPIP9; RUN domain-containing protein 3B; Rap2-binding protein 9; Rap2-interacting protein 9; RPIP-9
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96NL0
-
表达区间
1-473 aa
-
氨基酸序列
MASRSLGGLS GIRGGGGGGG KKSLSARNAA VERRNLITVC RFSVKTLIDR SCFETIDDSS PEFNNFAAIL EQILSHRLKE ISQSCRWLAH LQIPLQGQVT WFGYESPRSF WDYIRVACRK VSQNCICSIE NMENVSSSRA KGRAWIRVAL MEKHLSEYIS TALRDFKTTR RFYEDGAIVL GEEANMLAGM LLGLNAIDFS FCLKGEGLDG SFPAVIDYTP YLKYIQSSDS ISSDEEELRT LGSSGSESST PENVGPPFLM DENSWFNKCK RVKQKYQLTL EQKGYLEELL RLRENQLSES VSQNKILLQR IEDSDLAHKL EKEQLEYIIV ELQDQLTVLK NNDLRSRQEL TAHLTNQWPS PGALDVNAVA LDTLLYRKHN KQWYEKSYQS LDQLSAEVSL SQTSLDPGQS QEGDGKQDTL NVMSEGKEDT PSLLGLCGSL TSVASYKSLT SLKSNDYLAS PTTEMTSPGL TPS
-
分子量
52.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RUNDC3B, a member of the RUN domain-containing protein family, has garnered attention in recent years due to its potential role in various biological processes, including cell proliferation, differentiation, and apoptosis. Research indicates that RUNDC3B may be involved in critical cellular pathways that regulate tumorigenesis and other diseases. Its expression patterns have been observed in multiple cancer types, suggesting a possible function as a tumor marker or therapeutic target. The structural and functional characterization of RUNDC3B through recombinant protein techniques has become pivotal for understanding its mechanism of action. By producing and purifying RUNDC3B as a recombinant protein, researchers aim to investigate its interactions with other cellular proteins and elucidate its role in oncogenic pathways. Further studies utilizing RUNDC3B could provide valuable insights into its potential implications in cancer biology and therapeutics, making it a promising candidate for further exploration in drug development and personalized medicine. As the scientific community continues to uncover the intricacies of RUNDC3B, it could pave the way for novel strategies in cancer treatment and highlight the significance of RUN domain proteins in cellular regulation.
